RNA, U6 small nuclear 101, pseudogene (RNU6-101P)

RNA, U6 small nuclear 101, pseudogene (RNU6-101P) is annotated as a pseudogene of the U6 small nuclear RNA family, meaning it is a non-functional, non-protein-coding genomic sequence similar to a gene, but lacking the ability to produce a functional RNA or protein product[2]. The functional U6 small nuclear RNA (not the pseudogene) is an essential component of the spliceosome, the complex that catalyzes removal of introns from pre-mRNA in eukaryotic cells[5][3]. The U6 pseudogenes, including RNU6-101P, are considered evolutionary "back-ups" or remnants, often generated by retrotransposition, and do not have a known biological function, disease association, or role as receptors, enzymes, transcription factors, or therapeutic targets[2][1][5]. Consequently, they are not targeted by drugs, do not serve as biomarkers, and do not present specific safety or therapeutic challenges. Pseudogenes like RNU6-101P can contribute to genome evolution and may participate in the formation of chimeric RNAs through rare molecular events, but their direct biological relevance in health or disease, outside of serving as raw genetic material, remains unproven[1]. Key issues: - RNU6-101P is not a therapeutically actionable target, receptor, enzyme, or biologically active molecule. - Listing it as a target is incorrect because, as a pseudogene, it has no known activity or druggability[2].

Other names

RNU6-101PRNA, U6 small nuclear 101, pseudogene